Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice
Sha Huang, Yuhua Wang, Shuwen Xie, et al.
Phytomedicine (2022) Vol. 101, pp. 154117-154117
Closed Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Integrated UHPLC-Q-Exactive Orbitrap HRMS and Serum Pharmacochemistry for the Investigation of Anti-hepatic Fibrosis Effect of BaoGanNing Decoction
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
Caveolin-1 protects against liver injury and lipid accumulation in alcoholic fatty liver via ferroptosis resistance
Weiju Xue, Ning Guo, Liang Shan, et al.
Molecular Immunology (2025) Vol. 181, pp. 53-65
Closed Access
Hsa_circ_0001944 Regulates FXR/TLR4 Pathway and Ferroptosis to Alleviate Nickel Oxide Nanoparticles-Induced Collagen Formation in LX-2 Cells
Haodong Zhou, Qingyang Chen, Lijiao Ma, et al.
Toxics (2025) Vol. 13, Iss. 4, pp. 265-265
Open Access
Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice
Lin Zhang, Haibo Zhang, Gu Jin-Hua, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109433-109433
Closed Access | Times Cited: 18
CAV1 promotes epithelial-to-mesenchymal transition (EMT) and chronic renal allograft interstitial fibrosis by activating the ferroptosis pathway
Qianguang Han, Bing Ni, Wei Bao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Isoliquiritigenin, an Extract from Licorice, Attenuates Dexamethasone‐Induced Muscle Atrophy via Akt/mTOR Pathway
Xin Jiao, Yuxin Zhang, Zengguang Wang, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
Zhi-Hong Ning, Xiuheng Wang, Yue Zhao, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114341-114341
Closed Access
The Antiobesity Mechanisms of Polygonatum cyrtonema Hua Based on Network Analysis and Experimental Validation In Vivo and In Vitro
Lihua Xing, Chenchen Zhao, Jun Xu, et al.
Journal of Food Biochemistry (2025) Vol. 2025, Iss. 1
Open Access
Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells
Zheng Wang, Mengqin Yuan, Lichao Yao, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Study on the mechanism of hsa_circ_0074763 regulating the miR-3667-3P/ACSL4 axis in liver fibrosis
Yanling Cheng, Tiantian Song, Jin Yao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Integrative insights into the role of CAV1 in ketogenic diet and ferroptosis in pancreatic cancer
Xue Liang, Ruo-Fei Tian, Ting Li, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Baicalin mitigates alcoholic-associated liver disease via SOCS1-driven reprogramming of macrophages
Sha Huang, Yuhua Wang, Jin Fu Wen, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Ferroptosis: action and mechanism of chemical/drug-induced liver injury
Li Zeng, Xueli Jin, Qing-Ao Xiao, et al.
Drug and Chemical Toxicology (2023), pp. 1-12
Closed Access | Times Cited: 9
Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis
Xue Li, Xinyi Xu, Sian Tao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
The potential of flavonoids in hepatic fibrosis: A comprehensive review
Wenbo Zhu, Jianwei Han, Liu Hua, et al.
Phytomedicine (2024) Vol. 133, pp. 155932-155932
Closed Access | Times Cited: 3
Identification of potential ferroptosis-related biomarkers and a pharmacological compound in diabetic retinopathy based on machine learning and molecular docking
Jingying Liu, Xiaozhuang Li, Yanhua Cheng, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine
Pei Liu, Wanli Liang, Rui‐Ting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Integration of network pharmacology and transcriptomics to explore the mechanism of isoliquiritigenin in treating heart failure induced by myocardial infarction
Lingxiao Zhang, Yuling Luan, Xinyue Ding, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117114-117114
Closed Access | Times Cited: 2
Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
Rui Tang, Jing Luo, Xiaoxia Zhu, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
Synthesis and in vivo evaluation of new steviol derivatives that protect against cardiomyopathy by inhibiting ferroptosis
Chao Xu, E Ou, Zhiyin Li, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106142-106142
Closed Access | Times Cited: 8
Guizhi Shaoyao Zhimu decoction inhibits neutrophil extracellular traps formation to relieve rheumatoid arthritis via gut microbial outer membrane vesicles
Haixin Ye, Hao Wang, Bingqi Han, et al.
Phytomedicine (2024) Vol. 136, pp. 156254-156254
Closed Access | Times Cited: 1
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis
Chuang Liu, Siqi Li, Changhao Zhang, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2571-2628
Closed Access | Times Cited: 3
New insights into fibrotic signaling in hepatocellular carcinoma
Shan Liang, Fengling Wang, Weiju Xue, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Natural molecule isoliquiritigenin mitigates MASH and liver fibrosis in mice by promoting autophagy through the PI3K/Akt signaling pathway
Rong Liu, Yu Zhang, Min Liu, et al.
The Journal of Nutritional Biochemistry (2024), pp. 109808-109808
Closed Access
Mairin from Huangqi Decoction Mitigates Liver Cirrhosis through Suppression of Pro-inflammatory Signaling Pathways: A Network Pharmacology and Experimental Study
Di Meng, Shuang Ren
The Natural Products Journal (2024) Vol. 14, Iss. 5
Closed Access

Scroll to top